Literature DB >> 33944982

Identification of functional cytochrome P450 and ferredoxin from Streptomyces sp. EAS-AB2608 by transcriptional analysis and their heterologous expression.

Shinya Okubo1, Eri Ena2, Akifumi Okuda2, Ikuko Kozone3,4, Junko Hashimoto3,4, Yoshie Nishitsuji4,5, Manabu Fujie5, Noriyuki Satoh5, Haruo Ikeda6, Kazuo Shin-Ya4,7.   

Abstract

Bioconversion using microorganisms and their enzymes is an important tool in many industrial fields. The discovery of useful new microbial enzymes contributes to the development of industries utilizing bioprocesses. Streptomyces sp. EAS-AB2608, isolated from a soil sample collected in Japan, can convert the tetrahydrobenzotriazole CPD-1 (a selective positive allosteric modulator of metabotropic glutamate receptor 5) to its hydroxylated form at the C4-(R) position. The current study was performed to identify the genes encoding the enzymes involved in CPD-1 bioconversion and to verify their function. To identify gene products responsible for the conversion of CPD-1, we used RNA sequencing to analyze EAS-AB2608; from its 8333 coding sequences, we selected two genes, one encoding cytochrome P450 (easab2608_00800) and the other encoding ferredoxin (easab2608_00799), as encoding desirable gene products involved in the bioconversion of CPD-1. The validity of this selection was tested by using a heterologous expression approach. A bioconversion assay using genetically engineered Streptomyces avermitilis SUKA24 ∆saverm3882 ∆saverm7246 co-expressing the two selected genes (strain ES_SUKA_63) confirmed that these gene products had hydroxylation activity with respect to CPD-1, indicating that they are responsible for the conversion of CPD-1. Strain ES_SUKA_63 also showed oxidative activity toward other compounds and therefore might be useful not only for bioconversion of CPD-1 but also as a tool for synthesis of drug metabolites and in optimization studies of various pharmaceutical lead compounds. We expect that this approach will be useful for bridging the gap between the latest enzyme optimization technologies and conventional enzyme screening using microorganisms. KEY POINTS: • Genes easab2608_00800 (cyp) and easab2608_00799 (fdx) were selected by RNA-Seq. • Selection validity was evaluated by an engineered S. avermitilis expression system. • Strain ES_SUKA_63 showed oxidative activity toward CPD-1 and other compounds.

Entities:  

Keywords:  Actinobacteria; Bioconversion; Heterologous expression; Oxidative reaction; RNA sequencing

Year:  2021        PMID: 33944982     DOI: 10.1007/s00253-021-11304-z

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  29 in total

Review 1.  Taxonomy, Physiology, and Natural Products of Actinobacteria.

Authors:  Essaid Ait Barka; Parul Vatsa; Lisa Sanchez; Nathalie Gaveau-Vaillant; Cedric Jacquard; Jan P Meier-Kolthoff; Hans-Peter Klenk; Christophe Clément; Yder Ouhdouch; Gilles P van Wezel
Journal:  Microbiol Mol Biol Rev       Date:  2015-11-25       Impact factor: 11.056

Review 2.  Genome mining of the Streptomyces avermitilis genome and development of genome-minimized hosts for heterologous expression of biosynthetic gene clusters.

Authors:  Haruo Ikeda; Shin-ya Kazuo; Satoshi Omura
Journal:  J Ind Microbiol Biotechnol       Date:  2013-08-29       Impact factor: 3.346

Review 3.  Industrial applications of enzyme biocatalysis: Current status and future aspects.

Authors:  Jung-Min Choi; Sang-Soo Han; Hak-Sung Kim
Journal:  Biotechnol Adv       Date:  2015-03-06       Impact factor: 14.227

4.  Permeabilization induced by lipid II-targeting lantibiotic nisin and its effect on the bioconversion of vitamin D3 to 25-hydroxyvitamin D3 by Rhodococcus erythropolis.

Authors:  Noriko Imoto; Taiki Nishioka; Tomohiro Tamura
Journal:  Biochem Biophys Res Commun       Date:  2011-01-13       Impact factor: 3.575

5.  Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.

Authors:  S J Baldwin; S E Clarke; R J Chenery
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

6.  Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis.

Authors:  Haruo Ikeda; Jun Ishikawa; Akiharu Hanamoto; Mayumi Shinose; Hisashi Kikuchi; Tadayoshi Shiba; Yoshiyuki Sakaki; Masahira Hattori; Satoshi Omura
Journal:  Nat Biotechnol       Date:  2003-04-14       Impact factor: 54.908

7.  Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition.

Authors:  John M Ellard; Andrew Madin; Oliver Philps; Mark Hopkin; Scott Henderson; Louise Birch; Desmond O'Connor; Tohru Arai; Kazuma Takase; Louise Morgan; David Reynolds; Sonia Talma; Eimear Howley; Ben Powney; Andrew H Payne; Adrian Hall; Jane E Gartlon; Lee A Dawson; Luis Castro; Peter J Atkinson
Journal:  Bioorg Med Chem Lett       Date:  2015-10-17       Impact factor: 2.823

8.  Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Authors:  R W Burg; B M Miller; E E Baker; J Birnbaum; S A Currie; R Hartman; Y L Kong; R L Monaghan; G Olson; I Putter; J B Tunac; H Wallick; E O Stapley; R Oiwa; S Omura
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

9.  Mining of the Uncharacterized Cytochrome P450 Genes Involved in Alkaloid Biosynthesis in California Poppy Using a Draft Genome Sequence.

Authors:  Kentaro Hori; Yasuyuki Yamada; Ratmoyo Purwanto; Yohei Minakuchi; Atsushi Toyoda; Hideki Hirakawa; Fumihiko Sato
Journal:  Plant Cell Physiol       Date:  2018-02-01       Impact factor: 4.927

10.  Identification and expression of the 11β-steroid hydroxylase from Cochliobolus lunatus in Corynebacterium glutamicum.

Authors:  Carmen Felpeto-Santero; Beatriz Galán; José M Luengo; José M Fernández-Cañon; Carlos Del Cerro; Francisco J Medrano; José L García
Journal:  Microb Biotechnol       Date:  2019-06-14       Impact factor: 5.813

View more
  1 in total

Review 1.  Recent Advances in Biocatalysis for Drug Synthesis.

Authors:  Alina Kinner; Philipp Nerke; Regine Siedentop; Till Steinmetz; Thomas Classen; Katrin Rosenthal; Markus Nett; Jörg Pietruszka; Stephan Lütz
Journal:  Biomedicines       Date:  2022-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.